Ausgabe 12/2015
Inhalt (12 Artikel)
Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer
Keith L. Knutson, Matthew J. Maurer, Claudia C. Preston, Kirsten B. Moysich, Krista Goergen, Kieran M. Hawthorne, Julie M. Cunningham, Kunle Odunsi, Lynn C. Hartmann, Kimberly R. Kalli, Ann L. Oberg, Ellen L. Goode
RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML
Felix S. Lichtenegger, Isabell Kondla, Michael Krempasky, Anna L. Weber, Tobias Herold, Christina Krupka, Karsten Spiekermann, Stephanie Schneider, Thomas Büchner, Wolfgang E. Berdel, Bernhard J. Wörmann, Wolfgang Hiddemann, Marion Subklewe
Modification of cytokine-induced killer cells with chimeric antigen receptors (CARs) enhances antitumor immunity to epidermal growth factor receptor (EGFR)-positive malignancies
Xuequn Ren, Wanli Ma, Hong Lu, Lei Yuan, Lei An, Xicai Wang, Guanchang Cheng, Shuguang Zuo
Defining the effects of age and gender on immune response and outcomes to melanoma vaccination: a retrospective analysis of a single-institution clinical trials’ experience
Adriana G. Ramirez, Nolan A. Wages, Yinin Hu, Mark E. Smolkin, Craig L. Slingluff Jr.
Late administration of murine CTLA-4 blockade prolongs CD8-mediated anti-tumor effects following stimulatory cancer immunotherapy
Gail D. Sckisel, Annie Mirsoian, Myriam N. Bouchlaka, Julia K. Tietze, Mingyi Chen, Bruce R. Blazar, William J. Murphy
Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer
Daniel Delitto, Chelsey Perez, Song Han, David H. Gonzalo, Kien Pham, Andrea E. Knowlton, Christina L. Graves, Kevin E. Behrns, Lyle L. Moldawer, Ryan M. Thomas, Chen Liu, Thomas J. George Jr., Jose G. Trevino, Shannon M. Wallet, Steven J. Hughes
Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients
Hiromitsu Araki, Xiaoliang Pang, Nobukazu Komatsu, Mikiko Soejima, Nawoe Miyata, Mari Takaki, Shigeru Muta, Tetsuro Sasada, Masanori Noguchi, Yoshiro Koda, Kyogo Itoh, Satoru Kuhara, Kosuke Tashiro
Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivo
Christian Cremer, Hanna Braun, Radoslav Mladenov, Lea Schenke, Xiaojing Cong, Edgar Jost, Tim H. Brümmendorf, Rainer Fischer, Paolo Carloni, Stefan Barth, Thomas Nachreiner
Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator
Han Zhang, Ze-Lei Li, Shu-Biao Ye, Li-Ying Ouyang, Yu-Shan Chen, Jia He, Hui-Qiang Huang, Yi-Xin Zeng, Xiao-Shi Zhang, Jiang Li
Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients
Luciane Zabijak, Christophe Attencourt, Caroline Guignant, Denis Chatelain, Paulo Marcelo, Jean-Pierre Marolleau, Emmanuel Treiner
Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination
Gaute Lund Hansen, Gustav Gaudernack, Paal Fredrik Brunsvig, Milada Cvancarova, Jon Amund Kyte
Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone
Christian Krug, Katrin Birkholz, Alexander Paulus, Michael Schwenkert, Patrick Schmidt, Nicole Hoffmann, Andreas Hombach, Georg Fey, Hinrich Abken, Gerold Schuler, Beatrice Schuler-Thurner, Jan Dörrie, Niels Schaft